Summary

Acne vulgaris (acne) is a chronic inflammatory skin disease that presents as open or closed comedones and inflammatory lesions. Comedones include blackheads and whiteheads, while inflammatory lesions include papules, pustules, or cysts. Acne is a common skin disease that predominantly affects adolescents and young adults, but can also persist into adulthood. Mortality is not associated with acne, although major physical and psychological characteristics may develop, such as acne scarring, poor self-esteem, depression, and anxiety. The distribution of acne in the population is influenced by genetic background and dietary habits.

In the 7MM, epidemiologists forecast that the total prevalent cases of acne vulgaris will decrease by an Annual Growth Rate (AGR) of negative 0.13% per year over the next 10 years, to about 155.9 million cases in 2026. In the 7MM, the US had the highest number of total prevalent cases with over 64 million cases in 2016, while Spain had the lowest number of total prevalent cases in 2016. In the 7MM, the 18-60 year age group had the highest number of total prevalent cases of acne vulgaris, contributing approximately three-quarters of cases to the total in 2016. In the combined 7MM in 2016, total prevalent cases of acne vulgaris were higher in women compared with men, with around 93.6 million (approximately 60%) cases occurring in women and approximately 40% cases occurring in men.

The report "Acne Vulgaris - Epidemiology Forecast to 2026", provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).


Scope

  • The Acne Vulgaris report provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).
  • The acne vulgaris epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.




Reasons To Buy

The Acne Vulgaris Epidemiology report will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global acne vulgaris market.
  • Quantify patient populations in the global acne vulgaris market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne vulgaris therapeutics in each of the markets covered.
  • Understand magnitude of acne vulgaris population by disease severity.